Lacosamide Tablets - Global and China Top Players Market Share and Ranking 2023
According to the research report, the global market for Lacosamide Tablets should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Lacosamide Tablets market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Lacosamide Tablets market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Adults grew percent to account for percent of the total market sales, and Children grew percent.
The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs ("complementary therapy") to treat focal seizures (seizures that start in one area of the brain).
This report studies and analyses global Lacosamide Tablets status and future trends, helps the client to determine the Lacosamide Tablets market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Lacosamide Tablets, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Report Highlights
(1) Global Lacosamide Tablets market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Lacosamide Tablets sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Lacosamide Tablets sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Lacosamide Tablets key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Lacosamide Tablets key producing regions, capacity, production, and year over year growth
(6) Lacosamide Tablets industry chains, upstream, midstream and downstream
Market segment by players, this report covers
UCB
Aesica Pharmaceuticals GmbH
Teva
MSN Laboratories
Alembic Pharma
Glenmark
Accord Healthcare
Mylan
Sun PharmaApotex
Jiangxi Qingfeng Pharmaceutical
Beijing Sihuan Pharmaceutical
Buchang Pharmaceutical
Market segment by Type, covers
50 mg/tablet
100 mg/tablet
150 mg/tablet
200 mg/tablet
Market segment by Application, can be divided into
Adults
Children
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Key Findings from The Report:
Chapter 1: to describe Lacosamide Tablets product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Lacosamide Tablets market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Lacosamide Tablets market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Lacosamide Tablets, percent & CAGR, 2018-2029
Chapter 5: Lacosamide Tablets industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Lacosamide Tablets Definition
1.2 Global Lacosamide Tablets Market Size and Forecast
1.2.1 By Consumption Value, Global Lacosamide Tablets Market Size，2018-2029
1.2.2 By Sales Quantity, Global Lacosamide Tablets Market Size，2018-2029
1.2.3 Global Lacosamide Tablets Average Selling Price (ASP)，2018-2029
1.3 China Lacosamide Tablets Market Size and Forecast
1.3.1 By Consumption Value, China Lacosamide Tablets Market Size，2018-2029
1.3.2 By Sales Quantity, China Lacosamide Tablets Market Size，2018-2029
1.3.3 China Lacosamide Tablets Average Selling Price (ASP)， 2018-2029
1.4 Share of China Lacosamide Tablets Market with Respect to the Global Market
1.4.1 By Consumption Value, China Lacosamide Tablets Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Lacosamide Tablets Market Share in Global, 2018-2029
1.4.3 Lacosamide Tablets Market Size: China VS Global, 2018-2029
1.5 Lacosamide Tablets Market Dynamics
1.5.1 Lacosamide Tablets Market Drivers
1.5.2 Lacosamide Tablets Market Restraints
1.5.3 Lacosamide Tablets Industry Trends
1.5.4 Lacosamide Tablets Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Lacosamide Tablets, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Lacosamide Tablets, Global Market Share by Company, 2018-2023
2.3 Lacosamide Tablets Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Lacosamide Tablets Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Lacosamide Tablets Concentration Ratio
2.6 Global Lacosamide Tablets Mergers & Acquisitions, Expansion Plans
2.7 Global Lacosamide Tablets Manufacturers Product Type
2.8 Head Office and Lacosamide Tablets Production Site of Key Manufacturer
2.9 Lacosamide Tablets Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Lacosamide Tablets, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Lacosamide Tablets, China Market Share by Company, 2018-2023
3.3 China Lacosamide Tablets Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Lacosamide Tablets Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Lacosamide Tablets Capacity by Region
4.3 Global Lacosamide Tablets Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Lacosamide Tablets Production by Region, 2018-2029
4.5 Global Lacosamide Tablets Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Lacosamide Tablets Industry Chain
5.2 Lacosamide Tablets Upstream Analysis
5.2.1 Lacosamide Tablets Core Raw Materials
5.2.2 Main Manufacturers of Lacosamide Tablets Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Lacosamide Tablets Production Mode
5.6 Lacosamide Tablets Procurement Model
5.7 Lacosamide Tablets Industry Sales Model and Sales Channels
5.7.1 Lacosamide Tablets Sales Model
5.7.2 Lacosamide Tablets Typical Distributors
6 Sights by Type
6.1 Lacosamide Tablets Classification
6.1.1 50 mg/tablet
6.1.2 100 mg/tablet
6.1.3 150 mg/tablet
6.1.4 200 mg/tablet
6.2 By Type, Global Lacosamide Tablets Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Lacosamide Tablets Consumption Value, 2018-2029
6.4 By Type, Global Lacosamide Tablets Sales Quantity, 2018-2029
6.5 By Type, Global Lacosamide Tablets Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Lacosamide Tablets Segment by Application
7.1.1 Adults
7.1.2 Children
7.2 By Application, Global Lacosamide Tablets Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Lacosamide Tablets Consumption Value, 2018-2029
7.4 By Application, Global Lacosamide Tablets Sales Quantity, 2018-2029
7.5 By Application, Global Lacosamide Tablets Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Lacosamide Tablets Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Lacosamide Tablets Consumption Value, 2018-2029
8.3 By Region, Global Lacosamide Tablets Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Lacosamide Tablets & Forecasts, 2018-2029
8.4.2 By Country, North America Lacosamide Tablets Market Size Market Share
8.5 Europe
8.5.1 Europe Lacosamide Tablets Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Lacosamide Tablets Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Lacosamide Tablets Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Lacosamide Tablets Market Size Market Share
8.7 South America
8.7.1 South America Lacosamide Tablets Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Lacosamide Tablets Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Lacosamide Tablets Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Lacosamide Tablets Consumption Value, 2018-2029
9.3 By Country, Global Lacosamide Tablets Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Lacosamide Tablets Market Size, 2018-2029
9.4.2 By Type, U.S. Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Lacosamide Tablets Market Size, 2018-2029
9.5.2 By Type, Europe Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Lacosamide Tablets Market Size, 2018-2029
9.6.2 By Type, China Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Lacosamide Tablets Market Size, 2018-2029
9.7.2 By Type, Japan Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Lacosamide Tablets Market Size, 2018-2029
9.8.2 By Type, South Korea Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Lacosamide Tablets Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Lacosamide Tablets Market Size, 2018-2029
9.10.2 By Type, India Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Lacosamide Tablets Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 UCB
10.1.1 UCB Company Information, Head Office, Market Area, and Industry Position
10.1.2 UCB Lacosamide Tablets Models, Specifications, and Application
10.1.3 UCB Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 UCB Company Profile and Main Business
10.1.5 UCB Recent Developments
10.2 Aesica Pharmaceuticals GmbH
10.2.1 Aesica Pharmaceuticals GmbH Company Information, Head Office, Market Area, and Industry Position
10.2.2 Aesica Pharmaceuticals GmbH Lacosamide Tablets Models, Specifications, and Application
10.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Aesica Pharmaceuticals GmbH Company Profile and Main Business
10.2.5 Aesica Pharmaceuticals GmbH Recent Developments
10.3 Teva
10.3.1 Teva Company Information, Head Office, Market Area, and Industry Position
10.3.2 Teva Lacosamide Tablets Models, Specifications, and Application
10.3.3 Teva Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Teva Company Profile and Main Business
10.3.5 Teva Recent Developments
10.4 MSN Laboratories
10.4.1 MSN Laboratories Company Information, Head Office, Market Area, and Industry Position
10.4.2 MSN Laboratories Lacosamide Tablets Models, Specifications, and Application
10.4.3 MSN Laboratories Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 MSN Laboratories Company Profile and Main Business
10.4.5 MSN Laboratories Recent Developments
10.5 Alembic Pharma
10.5.1 Alembic Pharma Company Information, Head Office, Market Area, and Industry Position
10.5.2 Alembic Pharma Lacosamide Tablets Models, Specifications, and Application
10.5.3 Alembic Pharma Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Alembic Pharma Company Profile and Main Business
10.5.5 Alembic Pharma Recent Developments
10.6 Glenmark
10.6.1 Glenmark Company Information, Head Office, Market Area, and Industry Position
10.6.2 Glenmark Lacosamide Tablets Models, Specifications, and Application
10.6.3 Glenmark Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Glenmark Company Profile and Main Business
10.6.5 Glenmark Recent Developments
10.7 Accord Healthcare
10.7.1 Accord Healthcare Company Information, Head Office, Market Area, and Industry Position
10.7.2 Accord Healthcare Lacosamide Tablets Models, Specifications, and Application
10.7.3 Accord Healthcare Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Accord Healthcare Company Profile and Main Business
10.7.5 Accord Healthcare Recent Developments
10.8 Mylan
10.8.1 Mylan Company Information, Head Office, Market Area, and Industry Position
10.8.2 Mylan Lacosamide Tablets Models, Specifications, and Application
10.8.3 Mylan Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Mylan Company Profile and Main Business
10.8.5 Mylan Recent Developments
10.9 Sun PharmaApotex
10.9.1 Sun PharmaApotex Company Information, Head Office, Market Area, and Industry Position
10.9.2 Sun PharmaApotex Lacosamide Tablets Models, Specifications, and Application
10.9.3 Sun PharmaApotex Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Sun PharmaApotex Company Profile and Main Business
10.9.5 Sun PharmaApotex Recent Developments
10.10 Jiangxi Qingfeng Pharmaceutical
10.10.1 Jiangxi Qingfeng Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.10.2 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Models, Specifications, and Application
10.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Jiangxi Qingfeng Pharmaceutical Company Profile and Main Business
10.10.5 Jiangxi Qingfeng Pharmaceutical Recent Developments
10.11 Beijing Sihuan Pharmaceutical
10.11.1 Beijing Sihuan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.11.2 Beijing Sihuan Pharmaceutical Lacosamide Tablets Models, Specifications, and Application
10.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Beijing Sihuan Pharmaceutical Company Profile and Main Business
10.11.5 Beijing Sihuan Pharmaceutical Recent Developments
10.12 Buchang Pharmaceutical
10.12.1 Buchang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.12.2 Buchang Pharmaceutical Lacosamide Tablets Models, Specifications, and Application
10.12.3 Buchang Pharmaceutical Lacosamide Tablets Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Buchang Pharmaceutical Company Profile and Main Business
10.12.5 Buchang Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Lacosamide Tablets Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Lacosamide Tablets Market Restraints
Table 3. Lacosamide Tablets Market Trends
Table 4. Lacosamide Tablets Industry Policy
Table 5. Global Lacosamide Tablets Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Lacosamide Tablets Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Lacosamide Tablets Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Lacosamide Tablets Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Lacosamide Tablets Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Lacosamide Tablets Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Lacosamide Tablets Mergers & Acquisitions, Expansion Plans
Table 12. Global Lacosamide Tablets Manufacturers Product Type
Table 13. Head Office and Lacosamide Tablets Production Site of Key Manufacturer
Table 14. Lacosamide Tablets Capacity of Major Manufacturers and Future Plan
Table 15. China Lacosamide Tablets Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Lacosamide Tablets Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Lacosamide Tablets Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Lacosamide Tablets Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Lacosamide Tablets Production by Region, 2018-2023, (K Units)
Table 20. Global Lacosamide Tablets Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Lacosamide Tablets Upstream (Raw Materials)
Table 22. Global Lacosamide Tablets Typical Customers
Table 23. Lacosamide Tablets Typical Distributors
Table 24. By Type, Global Lacosamide Tablets Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Lacosamide Tablets Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Lacosamide Tablets Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Lacosamide Tablets Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Lacosamide Tablets Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Lacosamide Tablets Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Lacosamide Tablets Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Lacosamide Tablets Sales Quantity Market Share, 2018-2029
Table 34. UCB Company Information, Head Office, Market Area, and Industry Position
Table 35. UCB Lacosamide Tablets Models, Specifications, and Application
Table 36. UCB Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. UCB Company Profile and Main Business
Table 38. UCB Recent Developments
Table 39. Aesica Pharmaceuticals GmbH Company Information, Head Office, Market Area, and Industry Position
Table 40. Aesica Pharmaceuticals GmbH Lacosamide Tablets Models, Specifications, and Application
Table 41. Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Aesica Pharmaceuticals GmbH Company Profile and Main Business
Table 43. Aesica Pharmaceuticals GmbH Recent Developments
Table 44. Teva Company Information, Head Office, Market Area, and Industry Position
Table 45. Teva Lacosamide Tablets Models, Specifications, and Application
Table 46. Teva Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Teva Company Profile and Main Business
Table 48. Teva Recent Developments
Table 49. MSN Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 50. MSN Laboratories Lacosamide Tablets Models, Specifications, and Application
Table 51. MSN Laboratories Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. MSN Laboratories Company Profile and Main Business
Table 53. MSN Laboratories Recent Developments
Table 54. Alembic Pharma Company Information, Head Office, Market Area, and Industry Position
Table 55. Alembic Pharma Lacosamide Tablets Models, Specifications, and Application
Table 56. Alembic Pharma Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Alembic Pharma Company Profile and Main Business
Table 58. Alembic Pharma Recent Developments
Table 59. Glenmark Company Information, Head Office, Market Area, and Industry Position
Table 60. Glenmark Lacosamide Tablets Models, Specifications, and Application
Table 61. Glenmark Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Glenmark Company Profile and Main Business
Table 63. Glenmark Recent Developments
Table 64. Accord Healthcare Company Information, Head Office, Market Area, and Industry Position
Table 65. Accord Healthcare Lacosamide Tablets Models, Specifications, and Application
Table 66. Accord Healthcare Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Accord Healthcare Company Profile and Main Business
Table 68. Accord Healthcare Recent Developments
Table 69. Mylan Company Information, Head Office, Market Area, and Industry Position
Table 70. Mylan Lacosamide Tablets Models, Specifications, and Application
Table 71. Mylan Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Mylan Company Profile and Main Business
Table 73. Mylan Recent Developments
Table 74. Sun PharmaApotex Company Information, Head Office, Market Area, and Industry Position
Table 75. Sun PharmaApotex Lacosamide Tablets Models, Specifications, and Application
Table 76. Sun PharmaApotex Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Sun PharmaApotex Company Profile and Main Business
Table 78. Sun PharmaApotex Recent Developments
Table 79. Jiangxi Qingfeng Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 80. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Models, Specifications, and Application
Table 81. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Jiangxi Qingfeng Pharmaceutical Company Profile and Main Business
Table 83. Jiangxi Qingfeng Pharmaceutical Recent Developments
Table 84. Beijing Sihuan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 85. Beijing Sihuan Pharmaceutical Lacosamide Tablets Models, Specifications, and Application
Table 86. Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Beijing Sihuan Pharmaceutical Company Profile and Main Business
Table 88. Beijing Sihuan Pharmaceutical Recent Developments
Table 89. Buchang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 90. Buchang Pharmaceutical Lacosamide Tablets Models, Specifications, and Application
Table 91. Buchang Pharmaceutical Lacosamide Tablets Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Buchang Pharmaceutical Company Profile and Main Business
Table 93. Buchang Pharmaceutical Recent Developments
List of Figures
Figure 1. Lacosamide Tablets Picture
Figure 2. Global Lacosamide Tablets Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Lacosamide Tablets Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Lacosamide Tablets Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Lacosamide Tablets Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Lacosamide Tablets Sales Quantity (K Units) & (2018-2029)
Figure 7. China Lacosamide Tablets Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Lacosamide Tablets Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Lacosamide Tablets Market Share of Global, 2018-2029
Figure 10. Global Lacosamide Tablets Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Lacosamide Tablets Key Participants, Market Share, 2022
Figure 12. Global Lacosamide Tablets Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Lacosamide Tablets Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Lacosamide Tablets Production Market Share & Forecast by Region, 2018-2029
Figure 15. Lacosamide Tablets Industry Chain
Figure 16. Lacosamide Tablets Procurement Model
Figure 17. Lacosamide Tablets Sales Model
Figure 18. Lacosamide Tablets Sales Channels, Direct Sales, and Distribution
Figure 19. 50 mg/tablet
Figure 20. 100 mg/tablet
Figure 21. 150 mg/tablet
Figure 22. 200 mg/tablet
Figure 23. By Type, Global Lacosamide Tablets Consumption Value, 2018-2029, US$ Million
Figure 24. By Type, Global Lacosamide Tablets Consumption Value Market Share, 2018-2029
Figure 25. By Type, Global Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Figure 26. By Type, Global Lacosamide Tablets Sales Quantity Market Share, 2018-2029
Figure 27. By Type, Global Lacosamide Tablets Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 28. Adults
Figure 29. Children
Figure 30. By Application, Global Lacosamide Tablets Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global Lacosamide Tablets Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Figure 33. By Application, Global Lacosamide Tablets Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global Lacosamide Tablets Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global Lacosamide Tablets Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global Lacosamide Tablets Sales Quantity Market Share, 2018-2029
Figure 37. North America Lacosamide Tablets Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America Lacosamide Tablets Consumption Value Market Share, 2022
Figure 39. Europe Lacosamide Tablets Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe Lacosamide Tablets Consumption Value Market Share, 2022
Figure 41. Asia Pacific Lacosamide Tablets Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific Lacosamide Tablets Consumption Value Market Share, 2022
Figure 43. South America Lacosamide Tablets Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America Lacosamide Tablets Consumption Value Market Share, 2022
Figure 45. Middle East & Africa Lacosamide Tablets Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Figure 47. By Type, U.S. Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, Europe Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 52. China Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, China Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, Japan Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, South Korea Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, Southeast Asia Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 64. India Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, India Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa Lacosamide Tablets Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, Middle East & Africa Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa Lacosamide Tablets Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|